Cargando…
Interferon, Mx, and viral countermeasures
The interferon system provides a powerful and universal intracellular defense mechanism against viruses. Knockout mice defective in IFN signaling quickly succumb to all kinds of viral infections. Likewise, humans with genetic defects in interferon signaling die of viral disease at an early age. Amon...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185553/ https://www.ncbi.nlm.nih.gov/pubmed/17683972 http://dx.doi.org/10.1016/j.cytogfr.2007.06.001 |
_version_ | 1783526780298067968 |
---|---|
author | Haller, Otto Kochs, Georg Weber, Friedemann |
author_facet | Haller, Otto Kochs, Georg Weber, Friedemann |
author_sort | Haller, Otto |
collection | PubMed |
description | The interferon system provides a powerful and universal intracellular defense mechanism against viruses. Knockout mice defective in IFN signaling quickly succumb to all kinds of viral infections. Likewise, humans with genetic defects in interferon signaling die of viral disease at an early age. Among the known interferon-induced antiviral mechanisms, the Mx pathway is one of the most powerful. Mx proteins belong to the dynamin superfamily of large GTPases and have direct antiviral activity. They inhibit a wide range of viruses by blocking an early stage of the viral replication cycle. Likewise, the protein kinase R (PKR), and the 2–5 OAS/RNaseL system represent major antiviral pathways and have been extensively studied. Viruses, in turn, have evolved multiple strategies to escape the IFN system. They try to go undetected, suppress IFN synthesis, bind and neutralize secreted IFN molecules, block IFN signaling, or inhibit the action of IFN-induced antiviral proteins. Here, we summarize recent findings about the astonishing interplay of viruses with the IFN response pathway. |
format | Online Article Text |
id | pubmed-7185553 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71855532020-04-28 Interferon, Mx, and viral countermeasures Haller, Otto Kochs, Georg Weber, Friedemann Cytokine Growth Factor Rev Article The interferon system provides a powerful and universal intracellular defense mechanism against viruses. Knockout mice defective in IFN signaling quickly succumb to all kinds of viral infections. Likewise, humans with genetic defects in interferon signaling die of viral disease at an early age. Among the known interferon-induced antiviral mechanisms, the Mx pathway is one of the most powerful. Mx proteins belong to the dynamin superfamily of large GTPases and have direct antiviral activity. They inhibit a wide range of viruses by blocking an early stage of the viral replication cycle. Likewise, the protein kinase R (PKR), and the 2–5 OAS/RNaseL system represent major antiviral pathways and have been extensively studied. Viruses, in turn, have evolved multiple strategies to escape the IFN system. They try to go undetected, suppress IFN synthesis, bind and neutralize secreted IFN molecules, block IFN signaling, or inhibit the action of IFN-induced antiviral proteins. Here, we summarize recent findings about the astonishing interplay of viruses with the IFN response pathway. Elsevier Ltd. 2007 2007-08-01 /pmc/articles/PMC7185553/ /pubmed/17683972 http://dx.doi.org/10.1016/j.cytogfr.2007.06.001 Text en Copyright © 2007 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Haller, Otto Kochs, Georg Weber, Friedemann Interferon, Mx, and viral countermeasures |
title | Interferon, Mx, and viral countermeasures |
title_full | Interferon, Mx, and viral countermeasures |
title_fullStr | Interferon, Mx, and viral countermeasures |
title_full_unstemmed | Interferon, Mx, and viral countermeasures |
title_short | Interferon, Mx, and viral countermeasures |
title_sort | interferon, mx, and viral countermeasures |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185553/ https://www.ncbi.nlm.nih.gov/pubmed/17683972 http://dx.doi.org/10.1016/j.cytogfr.2007.06.001 |
work_keys_str_mv | AT hallerotto interferonmxandviralcountermeasures AT kochsgeorg interferonmxandviralcountermeasures AT weberfriedemann interferonmxandviralcountermeasures |